Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $37.40 | Total: $187.00 |
| 1 | 10 | $31.68 | Total: $316.80 |
| 1 | 25 | $26.84 | Total: $671.00 |
| 1 | 50 | $22.88 | Total: $1,144.00 |
| 1 | 100 | $19.80 | Total: $1,980.00 |
Overview
Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
Chemical Properties
| Molecular Formula | C16H15ClFN3O2 |
| Molecular Weight | 335.76 |
| CAS Numbers | 51213-99-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(NC(NC1=CC=C(Cl)C=C1)=O)(=O)C2=C(N(C)C)C=CC=C2F |
Storage and Handling
0C Short Term, -20C Long Term
References
Jonkman-de Vries J D , Bj V D B , ten Bokkel-Huinink W W , et al. Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur[J]. Pda J Pharm Sci Technol, 1997, 51[2] 89-95.